The present study first demonstrated that there is a high level of HCCAT5 expression in tumor tissues in comparison to peripheral noncancerous tissues of patients with GC, suggesting a potential oncogenic role for HCCAT5 in these individuals. The gene discussed is HCCAT5; the disease is neoplasm.